The precise events associated with B cell activation in humans are a subjectofintense investigation. It has been difficult to develop an in vitro model of antigen-specific triggering of antibody synthesis by human peripheral blood mononuclear cells that is independent of exogenous, mitogens. In the present study a sensitive and reproducible culture system and enzymelinked immunosorbent assay have been established wherein antigen alone is used to trigger antigen-specific antibody synthesis by mononuclear cells from subjects immunized to keyhole limpet hemocyanin (KLH (1, 2). Recent studies using a radioimmunoassay have demonstrated antigen-induced triggering of specific antibody responses in peripheral blood mononuclear cells of individuals who had experienced natural infection with influenza virus (13). The present study describes a highly sensitive and reproducible system for the antigen-induced triggering and measurement of specific antibody production by peripheral blood B cells of normal subjects who had been immunized in vivo with the soluble antigen keyhole limpet hemocyanin (KLH). In addition, it examines the roles of antigen and PWM in the in vitro induction of specific and polyclonal antibody synthesis, as well as the phenomenon ofantigen-specific suppression.MATERIALS AND-METHODS Immunization. Normal human subjects received a primary subcutaneous immunization of 5 mg of KLH (Calbiochem, La Jolla, CA) followed by a 2-week booster immunization. Low levels of anti-KLH antibodies were present in the sera of all subjects prior to immunization, as has been previously reported (14). After booster immunization, a 20-to 50-fold increase of IgM and IgG anti-KLH antibodies was noted in the sera. In vitro studies were performed approximately 2 weeks after the booster immunization.Cell Separation and Culture Conditions. Human peripheral blood mononuclear cells were separated by Hypaque/Ficoll gradient centrifugation and cultured in RPMI-1640 medium supplemented with gentamicin at 0.01 mg/ml, 2 mM. L-glutamine, trypticase soy broth at 0.03 mg/100 ml, and 10% heatinactivated fetal calf serum (Flow Laboratories, McLean, VA The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.